NorthWest Biotherapeutics Inc (NWBO)

[Know-Fear]

In biologics there is more art to the science. Unlike mainstream BP where upon a drug patent expiration any pharmaceutical entity can simply start manufacturing their version of the drug and no trials are required. In biologics what amounts to a phase III trial is required to prove another entity can accomplish the art of the science as its not as easy as simply copying a formula or patent.